Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × Doxorubicin × Clear all

NCT01705158 2023-09-06

MYCA

Phase 1/2 Completed

Ovarian Neoplasms

NCT00562185 2017-11-20

Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer

Phase 1/2 Withdrawn

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01637532 2016-01-26

PITCH

Phase 1/2 Completed

Ovarian Neoplasms